8-K
Greater Cannabis Company, Inc. (GCAN)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
D.C. 20549
FORM
8-K
CURRENT
REPORT
PURSUANT
TO SECTION 13 OR 15(d) OF THE
SECURITIES
EXCHANGE ACT OF 1934
April3, 2025
Date
of Report (Date of earliest event reported)
The
Greater Cannabis Company Inc.
(Exact Name of Registrant as Specified in Charter)
| Florida | 000-56027 | 30-0842570 |
|---|---|---|
| (State<br> or other jurisdiction<br><br> <br>of<br> incorporation) | (Commission<br><br> <br>File<br> Number) | (IRS<br> Employer<br><br> <br>Identification<br> No.) |
15Walker Ave**, Suite101**
Baltimore,
MD 21208
(Address of Principal Executive Offices)
(443)
738-4051
(Registrant’s telephone number, including area code)
N/A
(Former Name or Former Address, if Changed Since Last Report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
| ☐ | Written<br> communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
|---|---|
| ☐ | Soliciting<br> material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| ☐ | Pre-commencement<br> communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ☐ | Pre-commencement<br> communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
| Title<br> of each class | Trading<br> Symbol(s) | Name<br> of each exchange on which registered |
|---|---|---|
| None | GCAN | None |
Emerging Growth Company ☐
As used in this Current Report on Form 8-K (this “Current Report”), and unless otherwise indicated, the terms “theCompany,” “GCAN,” “we,” “us” and “our” refer to The Greater Cannabis Company, Inc. and its subsidiaries.
Item3.02 Unregistered Sales of Equity Securities.
The disclosure set forth in Item 5.02 of this Current Report is incorporated herein by reference.
Item5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements ofCertain Officers.
On April 3, 2025, GCAN issued 100,000,000 restricted shares of its common stock (the “Shares”) to Aitan Zacharin, its Chief Executive Officer and director, in satisfaction of $10,000 in deferred compensation due him.
The Company issued the Shares pursuant to the exemption from the registration requirements of the Securities Act of 1922, as amended (the “Securities Act”), afforded by Section 4(a)(2) of the Securities Act.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| The Greater Cannabis Company, Inc. <br><br> a Florida corporation | ||
|---|---|---|
| Dated:<br> April 10, 2025 | By: | /s/ Aitan Zacharin |
| Chief<br> Executive Officer |